APYX

Apyx Medical Corporation Common Stock

APYX
Closed
$4.46
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 205 full-time employees. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.
Country

US

CEO

Mr. Charles Goodwin

IPO date

1983

Employees

205

ISIN

US03837C1062

Key stats

Open

$4.21

Volume

40.33K

Market cap

$176.45M

Prev. close

$4.46

Impl / hst vl

-

Open interest

$0.00

$4.21

Day’s Range

$4.49

$2.76

52W Range

$5.08

Valuation

50
Valuation score
Fairly Valued
P/E
-
P/S
3.15
P/B
13.70
Current ratio
5.80
Debt / Equity
0.31
ROE
-90.62%
Gross margin
63.45%
Income growth
62.28%
FCF growth
-77.47

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$6.63
The top 6 analysts forecasts that 12-month price may increase by 48.65%, with a low of $6.06 and a high of $8.40
$6.06
Low
$6.63
Avg
$8.40
High
Current price

Earnings

Q1 ‘26 revenue
$12.49M
Q1 ‘26 net income
-$2.11M
Revenue
Net income
Previous EPS
-$0.05
Estimate EPS
-$0.09
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply